We are live on
!
Find out more
1832 Asset Management Portfolio holdings
AUM
$109B
1-Year Est. Return
35.56%
This Fund
S&P 500
This Quarter
Est. Return
+8.69%
1 Year Est. Return
+35.56%
3 Year Est. Return
+103.97%
5 Year Est. Return
+158.4%
10 Year Est. Return
+632.54%
AUM
$60.1B
AUM Growth
+$6.38B
(+12%)
Cap. Flow
+$2.85B
Cap. Flow
% of AUM
4.74%
Top 10 Holdings %
Top 10 Hldgs %
35.51%
Holding
996
New
112
Increased
271
Reduced
364
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$217M |
| 2 |
Chubb
CB
|
+$195M |
| 3 |
Stryker
SYK
|
+$195M |
| 4 |
ExxonMobil
XOM
|
+$190M |
| 5 |
MongoDB
MDB
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$302M |
| 2 |
NextEra Energy
NEE
|
+$261M |
| 3 |
Blackstone
BX
|
+$253M |
| 4 |
Atlassian
TEAM
|
+$223M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.93% |
| 2 | Technology | 10.18% |
| 3 | Industrials | 9.41% |
| 4 | Healthcare | 9.12% |
| 5 | Consumer Discretionary | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Fastenal
FAST
$58.3B
| $2.32M | ﹤0.01% |
97,944
+390
| +0.4% | +$9.54K |
|
502
Travelers Companies
TRV
$80.5B
| $2.32M | ﹤0.01% |
12,359
-2,512
| -17% | -$452K |
|
|
FUSN
503
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.31M | ﹤0.01% |
734,321
| – | – |
|
504
Verizon
VZ
$195B
| $2.31M | ﹤0.01% |
58,616
-26,089
| -31% | -$983K |
|
505
Kimberly-Clark
KMB
$36.1B
| $2.31M | ﹤0.01% |
16,985
+378
| +2% | +$48K |
|
506
Keurig Dr Pepper
KDP
$41.3B
| $2.28M | ﹤0.01% |
+64,026
| New | +$2.4M |
|
507
3M
MMM
$93.2B
| $2.27M | ﹤0.01% |
22,657
+1,251
| +6% | +$128K |
|
508
J.M. Smucker
SJM
$12.7B
| $2.27M | ﹤0.01% |
+14,335
| New | +$2.14M |
|
509
AT&T
T
$162B
| $2.26M | ﹤0.01% |
122,647
-3,962
| -3% | -$70.9K |
|
510
ON Semiconductor
ON
$18.6B
| $2.17M | ﹤0.01% |
34,833
-1,853
| -5% | -$124K |
|
511
Gilead Sciences
GILD
$162B
| $2.16M | ﹤0.01% |
25,206
-6,961
| -22% | -$551K |
|
512
Vertex Pharmaceuticals
VRTX
$123B
| $2.16M | ﹤0.01% |
7,484
-41,441
| -85% | -$12.6M |
|
513
Regeneron Pharmaceuticals
REGN
$79.5B
| $2.15M | ﹤0.01% |
2,986
-653
| -18% | -$482K |
|
514
Valley National Bancorp
VLY
$8B
| $2.13M | ﹤0.01% |
188,247
+174,917
| +1,312% | +$2.06M |
|
515
NVR
NVR
$16.9B
| $2.12M | ﹤0.01% |
460
-20
| -4% | -$87.9K |
|
516
Brown-Forman Class B
BF.B
$13B
| $2.12M | ﹤0.01% |
+32,285
| New | +$2.19M |
|
517
CenterPoint Energy
CNP
$26.8B
| $2.11M | ﹤0.01% |
70,487
-18,651
| -21% | -$542K |
|
518
ICL Group
ICL
$6.8B
| $2.1M | ﹤0.01% |
286,909
+85,364
| +42% | +$707K |
|
519
Hartford Financial Services
HIG
$39.6B
| $2.08M | ﹤0.01% |
27,484
-3,635
| -12% | -$262K |
|
520
Invesco QQQ Trust
QQQ
$479B
| $2.08M | ﹤0.01% |
7,801
-68,660
| -90% | -$19M |
|
521
Quest Diagnostics
DGX
$26.3B
| $2.06M | ﹤0.01% |
13,180
-2,090
| -14% | -$300K |
|
522
iShares MSCI Japan ETF
EWJ
$22.5B
| $2.06M | ﹤0.01% |
37,786
+7,940
| +27% | +$418K |
|
523
Tapestry
TPR
$32.7B
| $2.06M | ﹤0.01% |
53,999
+49,966
| +1,239% | +$1.71M |
|
524
EQT Corp
EQT
$32.3B
| $2.05M | ﹤0.01% |
60,479
-21,521
| -26% | -$864K |
|
525
Citigroup
C
$224B
| $2.03M | ﹤0.01% |
44,918
+8,597
| +24% | +$391K |
|
Similar funds
VAM
1832 Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, 1832 Asset Management held 996 positions worth $60.1B, up 12% from $53.7B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
1832 Asset Management deployed $2.85B of net new capital in Q4 2022, opening 112 new positions and adding to 271 existing holdings. Its largest new stake was Brookfield Asset Management: 5,889,456 shares worth $169M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was UnitedHealth, an estimated $302M trimmed.
- 1832 Asset Management's largest Q4 2022 buy was Brookfield Asset Management: 5,889,456 shares worth $169M.
- 1832 Asset Management added most to Berkshire Hathaway Class B in Q4 2022, an estimated $217M increase.
- 1832 Asset Management's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $302M.
- 1832 Asset Management fully exited Atlassian in Q4 2022, selling an estimated $223M.
- 1832 Asset Management's ten largest holdings make up 36% of its $60.1B portfolio in Q4 2022.
- 1832 Asset Management opened 112 new positions and closed 110 in Q4 2022.
- 1832 Asset Management's portfolio value rose 12% quarter-over-quarter to $60.1B.
Based on 1832 Asset Management's 13F filing for Q4 2022, filed 15 Feb 2023.